Despite skiing's complicated phrases, slang, and descriptors when it comes to snow and gear, the sport uses a rather simple ...
Servier will be responsible for development and global commercialisation of the therapy for several indications.
Stock analysts at HC Wainwright dropped their Q1 2025 earnings per share (EPS) estimates for Black Diamond Therapeutics in a ...
Wedbush reissued their outperform rating on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a research ...
Black Diamond said Servier will develop and commercialize BDTX-4933, a small molecule designed by the Cambridge, Mass., company to address unmet medical needs in RAF/RAS-mutant solid tumors.
Shares of Black Diamond Therapeutics, Inc. (BDTX) jumped around 21% as of Wednesday noon after the company announced it had ...
Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...
Black Diamond Equipment has announced a recall of all BD Vision Harnesses due to a potential fall hazard. This action is ...